PsyMed Ventures Newsletter

Share this post

Scaling psilocybin therapy: Compass Pathways' Lars Wilde

psymedventures.substack.com

Scaling psilocybin therapy: Compass Pathways' Lars Wilde

Business Trip, a podcast about psychedelic entrepreneurship

PsyMed Ventures
Aug 13, 2021
Share this post

Scaling psilocybin therapy: Compass Pathways' Lars Wilde

psymedventures.substack.com

Welcome back to Business Trip, a podcast about psychedelic entrepreneurship! 🍄

Episode 10 features Lars Wilde, co-founder and Chief Business Officer of Compass Pathways, a mental health company with an initial focus on psilocybin therapy for Treatment-Resistant Depression.

Listen now

In this episode, we discuss:

  • Lars’ experience overcoming Treatment-Resistant Depression with psilocybin

  • The nuances of clinical trials and psilocybin dosing protocols

  • Compass Pathways’ Intellectual Property strategy

  • What additional indications and therapies Compass Pathways is interested in

Listen to the episode here, on Spotify or Apple Podcasts.

When you’re done listening, tweet at us @businesstripfm to share your thoughts!


About Us

Business Trip tells the story of the emerging industry of psychedelics. Each episode features a new company in the field, ranging from biotech startups developing novel compounds, to clinics and retreats for healing, to software companies building tools to power the ecosystem. 

Business Trip is produced by Greg Kubin and Matias Serebrinsky — we’re advocates of the healing powers of psychedelic medicine and see a bright future ahead for the industry.

Thanks for listening,

Matias and Greg

💖 Know someone who would enjoy Business Trip?

Follow us on Twitter & Instagram.

Share this post

Scaling psilocybin therapy: Compass Pathways' Lars Wilde

psymedventures.substack.com
Comments
TopNewCommunity

No posts

Ready for more?

© 2023 Business Trip
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing